Update two days in a row
Dear Shareholders,
This is a special CEO update to provide news related to our HeartCheck™ sales and marketing efforts. Please click here to download a copy of a Letter of Intent (LOI) provided under the approval of McKesson Canada, Specialty Division (McKesson). The LOI is self-explanatory.
As stated by CardioComm Solutions over the past few months, we have been working diligently to place the HeartCheck™ PEN and the SMART Monitoring ECG service into pharmacies in Canada. Pharmacies are a very appropriate setting for the recommended use of an ECG screening solution, performed by pharmacists, on persons who are at risk for arrhythmia based cardiac diseases.
In October we initiated an aggressive marketing campaign which began with the launch of a CBC circulated TV commercial and the placement of HeartCheck™ PEN devices into pharmacies in Southern Ontario under the Total Health and Remedy’sRx pharmacy banner groups. In November and December we have been scheduling the setup of the HeartCheck Partner Program in these pharmacies. While doing so, we have also continued to look at additional and larger pharmacy banner groups.
We view this LOI to be an important milestone in our efforts of expanding HeartCheck™ ECG screening and monitoring services into the consumer market. We have worked hard to secure independent regulatory and clinical validation of our technologies, and are now focused on the sales and implementation of the HeartCheck™ PEN and SMART Monitoring ECG screening services into pharmacies and other verticals globally.
We are grateful to have been permitted to share this update with our shareholders. Details regarding the project will be disclosed at a later date and any press releases will be made in accordance with non-disclosure details that are currently in place.
More information regarding the HeartCheck™ products and SMART monitoring solutions is available at the Company’s website www.theheartcheck.com.
About McKesson Canada
Founded more than 100 years ago, McKesson Canada is dedicated to delivering vital medicines, supplies and information technologies that enable the health care industry to provide patients with better, safer care. The company’s solutions empower pharmacies, manufacturers, hospitals and other health care institutions by enabling them to get closer to the millions of patients they serve every single day, while contributing to the quality and safety of care in Canada.
Forward-looking statements
This release may contain certain forward-looking statements with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements.